Webinar – Beyond patents: unlocking smarter IP decisions with non-patent literature

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Webinar – Beyond patents: unlocking smarter IP decisions with non-patent literature

Sponsored by

Logo 22.07.22.png
article banner.png

Join MIP and CAS on April 14 for a webinar exploring how non-patent literature can assist intellectual property teams in spotting innovation early, reducing risks, and making faster, smarter decisions

Non-patent literature (NPL) is an increasingly vital part of intellectual property (IP) strategy, helping teams identify emerging trends, assess freedom to operate, and enrich patent landscapes. In this webinar, CAS reveals how IP professionals can unlock the hidden insights in publications, product releases, and technical reports that go beyond patent databases.

Matthew J McBride, director of CAS IP Services, and Kathy Van der Herten, director of product management at CAS, will share practical examples of how to integrate NPL into your workflows, from prior art searches to technology scouting.

Learn how early signals of innovation can give your team a competitive edge and how to navigate the challenges of volume, diversity, and credibility of NPL sources. The session will also highlight best practices for cross-functional collaboration, ongoing monitoring, and documentation, ensuring your NPL insights are actionable and reliable.

Whether you are strengthening novelty assessments, identifying potential risks, or exploring emerging technologies, the webinar will demonstrate how to transform IP decision-making.

A Q&A session at the end of the discussion will give you the chance to raise your specific IP challenges.

Register now for the webinar at 3pm BST (10am EST) on April 14 and start leveraging non-patent literature to maximise your IP strategy.

The speakers

Matt McBride.jpg

Matthew J McBride

Director, CAS IP Services

Matt is the director of CAS IP Services, managing all aspects of the business and working with customers to develop effective strategies for accessing and managing high-quality intellectual property information. Previously, he was a senior application specialist for the CAS STNext and CAS SciFinder platforms and held roles at Thomson Reuters and Rohm and Haas.

Matt earned a BSc in molecular biology from Purdue University, Indiana, an MSc in plant pathology from the University of Minnesota, and an MSc in business intelligence and analytics from Saint Joseph’s University, Philadelphia. He is a member of the Patent Information Users Group (PIUG) and the American Chemical Society.

Kathy Van der Herten.png

Kathy Van der Herten

Director of product management, CAS

Kathy is a product management leader with over 20 years of experience in the intellectual property (IP) industry, spanning both trademarks and patents. Since 2021, she has served as director of product management at CAS, where she leads the IP product solutions portfolio.

Based in Belgium and a regular visitor to the CAS offices in Columbus, Ohio, Kathy brings a global perspective and deep industry expertise to her role, driving innovation and delivering impactful solutions for IP professionals worldwide.

more from across site and SHARED ros bottom lb

More from across our site

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
Gift this article